Get the Stockscreener App
0.659
1.80%
-0.0121
After Hours:
.64
-0.019
-2.88%
Werewolf Therapeutics Inc stock is traded at $0.659, with a volume of 222.94K.
It is down -1.80% in the last 24 hours and up +14.69% over the past month.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.
See More
Previous Close:
$0.6711
Open:
$0.6777
24h Volume:
222.94K
Relative Volume:
0.36
Market Cap:
$31.99M
Revenue:
$19.94M
Net Income/Loss:
$-37.37M
P/E Ratio:
-0.6337
EPS:
-1.04
Net Cash Flow:
$-33.38M
1W Performance:
+8.75%
1M Performance:
+14.69%
6M Performance:
-45.08%
1Y Performance:
-56.64%
1-Day Range:
$0.6421
$0.6891
1-Week Range:
$0.60
$0.7442
52-Week Range:
$0.5301
$2.38
Werewolf Therapeutics Inc Stock (HOWL) Company Profile
Name
Werewolf Therapeutics Inc
Sector
Industry
Phone
617-952-0555
Address
200 TALCOTT AVENUE, WATERTOWN
Compare HOWL vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HOWL
Werewolf Therapeutics Inc
|
0.659 | 32.58M | 19.94M | -37.37M | -33.38M | -1.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Werewolf Therapeutics Inc Stock (HOWL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-19-25 | Downgrade | Wedbush | Outperform → Neutral |
| Apr-03-24 | Initiated | JMP Securities | Mkt Outperform |
| Aug-24-23 | Initiated | Wedbush | Outperform |
| Jun-06-23 | Resumed | Jefferies | Buy |
| Sep-10-21 | Initiated | BofA Securities | Buy |
| May-25-21 | Initiated | Evercore ISI | Outperform |
| May-25-21 | Initiated | H.C. Wainwright | Buy |
| May-25-21 | Initiated | Jefferies | Buy |
| May-25-21 | Initiated | SVB Leerink | Outperform |
View All
Werewolf Therapeutics Inc Stock (HOWL) Latest News
Aug Opening: Should I invest in Standard BioTools Inc before earningsWall Street Watch & AI Powered Market Trend Analysis - baoquankhu1.vn
Aug Ideas: Is now the right time to enter Werewolf Therapeutics Inc2025 Investor Takeaways & Capital Protection Trading Alerts - baoquankhu1.vn
Death Cross: Is now the right time to enter Werewolf Therapeutics Inc2025 Geopolitical Influence & Consistent Income Trade Ideas - baoquankhu1.vn
Risk Off: What is the target price for Custom Truck One Source Inc stock2025 EndofYear Setup & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Werewolf Therapeutics (HOWL) upgraded to buy: Here's what you should know - MSN
Trading Action: Does Werewolf Therapeutics Inc have strong EBITDA marginsJuly 2025 Momentum & AI Driven Stock Price Forecasts - baoquankhu1.vn
Werewolf Therapeutics receives Nasdaq notice for minimum bid price deficiency - Investing.com Nigeria
Werewolf Therapeutics Receives Nasdaq Minimum Bid Price Notice - TipRanks
Werewolf Therapeutics Received Notice of Noncompliance - TradingView
Bond Watch: What dividend growth rate does ZENA offerInsider Buying & Weekly Momentum Stock Picks - baoquankhu1.vn
Is Werewolf Therapeutics Inc stock trending bullish2025 Market Sentiment & Free Verified High Yield Trade Plans - baoquankhu1.vn
Evnin Luke, Werewolf Therapeutics director, sells $20,942 in Howl stock By Investing.com - Investing.com Australia
Evnin Luke, Werewolf Therapeutics director, sells $20,942 in Howl stock - Investing.com
Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Short Interest Update - Defense World
Movement Recap: Can Black Hawk Acquisition Corporation ride the EV waveGlobal Markets & Growth Focused Entry Point Reports - baoquankhu1.vn
Werewolf Therapeutics (HOWL) price target decreased by 10.86% to 5.30 - MSN
Evenin Luke sells Werewolf Therapeutics (HOWL) stock for $61k By Investing.com - Investing.com India
Evenin Luke sells Werewolf Therapeutics (HOWL) stock for $61k - Investing.com
Luke Evnin Sells 24,678 Shares of Werewolf Therapeutics (NASDAQ:HOWL) Stock - Defense World
Growth Value: Can Werewolf Therapeutics Inc stock double in next 5 yearsPortfolio Performance Report & Expert Curated Trade Setup Alerts - Bộ Nội Vụ
Werewolf Therapeutics (HOWL) Eyes 2026 Catalysts Following FDA Guidance and Encouraging INDUKINE Results - Yahoo Finance
Evnin Luke sells Werewolf Therapeutics (HOWL) shares for $53,533 - Investing.com UK
Evnin Luke sells Werewolf Therapeutics (HOWL) shares for $53,533 By Investing.com - Investing.com Canada
Risk Analysis: Will Werewolf Therapeutics Inc. stock benefit from infrastructure spending2025 Technical Patterns & Daily Growth Stock Tips - Улправда
Is Werewolf Therapeutics Inc. stock ready for breakout2025 Growth vs Value & High Win Rate Trade Tips - ulpravda.ru
10 Stocks Under $1 That Will Explode - Insider Monkey
Aug Analyst Calls: Can Werewolf Therapeutics Inc. stock hit analyst price targetsPortfolio Value Summary & Verified Technical Trade Signals - ulpravda.ru
How rising interest rates impact Werewolf Therapeutics Inc. stockJuly 2025 Opening Moves & Technical Analysis for Trade Confirmation - Улправда
Evnin Luke sells Werewolf Therapeutics (HOWL) stock for $45,882 - Investing.com UK
Evnin Luke sells Werewolf Therapeutics (HOWL) stock for $45,882 By Investing.com - Investing.com India
Luke Evnin Sells 34,847 Shares of Werewolf Therapeutics (NASDAQ:HOWL) Stock - Defense World
HOWL Stock Price, Forecast & Analysis | WEREWOLF THERAPEUTICS INC (NASDAQ:HOWL) - Chartmill
Will Werewolf Therapeutics Inc. stock return to pre crisis levelsAnalyst Upgrades & Capital Efficiency Improvement - bollywoodhelpline.com
Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Receives Consensus Rating of “Hold” from Analysts - Defense World
Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY) and Werewolf Therapeutics (HOWL) - The Globe and Mail
Market Moves: Is Werewolf Therapeutics Inc. stock ready for breakoutWeekly Trade Summary & Real-Time Stock Price Movement Reports - moha.gov.vn
Will Werewolf Therapeutics Inc. stock benefit from infrastructure spendingProduct Launch & Free Accurate Trade Setup Notifications - Улправда
Werewolf Therapeutics (NASDAQ:HOWL) Downgraded to “Neutral” Rating by Wedbush - Defense World
Why retail investors pile into Werewolf Therapeutics Inc. stockRisk Management & Technical Confirmation Trade Alerts - Улправда
HC Wainwright & Co. Maintains Werewolf Therapeutics (HOWL) Buy Recommendation - Nasdaq
Werewolf Therapeutics Inc Stock (HOWL) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.24%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):